These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3532975)

  • 21. The effect of experimental heterotopic pancreatic allotransplantation on the insulin response to oral glucose administration.
    Jensen SL; Kühl C; Nielsen OV
    Scand J Gastroenterol Suppl; 1976; 37():47-51. PubMed ID: 775617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Functional and morphological study of the pancreatic graft after segmental heterotopic autotransplantation in dogs].
    Imbaud P; Duron JJ; Dubois M; Olivier L; Ravel D; Challal S; Laurin S; Duhault J
    Chirurgie; 1993-1994; 119(3):113-20. PubMed ID: 7995116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Is functional demand a condition without which the pancreatic auto transplant can not survive in the dog's spleen?].
    Mosimann F; Mirkovitch V; Macarone-Palmieri R; Blanc D; Campiche M
    Helv Chir Acta; 1978 May; 45(1-2):157-9. PubMed ID: 350810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic endocrine responses to nutrients and bombesin after segmental pancreas autotransplantation in dogs.
    Dupre J; Grace DM; McDonald TJ; Inculet R; Leblanc B
    Pancreas; 1987; 2(1):99-105. PubMed ID: 3554227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of glipizide on the surgically altered pancreas.
    Barr JD; Parish ES; Krusch DA; Farris AH; Freedlender AH; Kaiser DL; Hanks JB
    Am J Surg; 1989 Jan; 157(1):103-8. PubMed ID: 2642663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative assessment of long-term changes in insulin secretion after canine duct-obliterated pancreas transplantation.
    Gooszen HG; van Schilfgaarde R; van der Burg MP; van Lawick van Pabst WP; Frölich M; Bosman FT
    Transplantation; 1988 Dec; 46(6):793-9. PubMed ID: 3061072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric inhibitory polypeptide secretion after radical pancreatoduodenectomy.
    Miyata M; Nakao K; Tanaka Y; Sakamoto T; Hamaji M; Taketani H; Kawashima Y
    Ann Surg; 1984 Mar; 199(3):281-5. PubMed ID: 6367676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Qualitative and quantitative changes in islet cells of autotransplanted pancreas in dogs in relation to glucose metabolism.
    Kaji H; Inoue K; Yun M; Uchida K; Sugiyama T; Tobe T
    Pancreas; 1992; 7(6):642-8. PubMed ID: 1280363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
    Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W
    J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
    Meier JJ; Gallwitz B; Askenas M; Vollmer K; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
    Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose and insulin metabolism after pancreatic transplantation.
    Sells RA; Calne RY; Hadjiyanakis V; Marshall VC
    Br Med J; 1972 Sep; 3(5828):678-81. PubMed ID: 4568357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of different dietary loads on glucose-dependent insulinotropic polypeptide in subjects with normal glucose tolerance].
    Chen Z; Yan L; Fu XY; Yang HZ; Kuang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):2031-4. PubMed ID: 22200706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced insulin secretion by subtotal pancreatectomy: preservation of insulin sensitivity and glucose tolerance in postoperative patients.
    Magnússon J; Bengmark S; Tranberg KG
    Scand J Gastroenterol; 1990 Jul; 25(7):669-75. PubMed ID: 2204104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans.
    Meier JJ; Holst JJ; Schmidt WE; Nauck MA
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E849-56. PubMed ID: 17609256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impairment of the insulinotropic effect of gastric inhibitory polypeptide (GIP) in obese and diabetic rats is related to the down-regulation of its pancreatic receptors.
    Younan SM; Rashed LA
    Gen Physiol Biophys; 2007 Sep; 26(3):181-93. PubMed ID: 18063845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in metabolic syndrome.
    Calanna S; Urbano F; Piro S; Zagami RM; Di Pino A; Spadaro L; Purrello F; Rabuazzo AM
    Eur J Endocrinol; 2012 May; 166(5):917-22. PubMed ID: 22391044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
    Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM
    Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of hypoglycemic activity of total lignans from Fructus Arctii in the spontaneously diabetic Goto-Kakizaki rats.
    Xu Z; Ju J; Wang K; Gu C; Feng Y
    J Ethnopharmacol; 2014; 151(1):548-55. PubMed ID: 24269245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of incretins in oral glucose and lipid tolerance tests may be indicative in the diagnosis of metabolic syndrome aggravation.
    Kiec-Klimczak M; Malczewska-Malec M; Razny U; Zdzienicka A; Gruca A; Goralska J; Pach D; Gilis-Januszewska A; Dembinska-Kiec A; Hubalewska-Dydejczyk A
    J Physiol Pharmacol; 2016 Apr; 67(2):217-26. PubMed ID: 27226181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.